- Filed
- Dec 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Dec 12, 2025 | 194.96M sh |
| Shares Diluted | Q2 2026 · Oct 31, 2025 | 183.56M sh |
| Shares Diluted | Q2 2026 · Oct 31, 2025 | 178.26M sh |
| Shares Diluted | Q2 2026 · Oct 31, 2024 | 108.4M sh |
| Shares Diluted | Q2 2026 · Oct 31, 2024 | 95.17M sh |
| Capex | Q2 2026 · Oct 31, 2025 | $1.72M |
| Capex | Q2 2026 · Oct 31, 2024 | $128K |
| Operating Cash Flow | Q2 2026 · Oct 31, 2025 | −$13.14M |
| Operating Cash Flow | Q2 2026 · Oct 31, 2024 | −$10.89M |
| Cash And Equivalents | Q2 2026 · Oct 31, 2025 | $11.66M |
| Cash And Equivalents | Q2 2026 · Apr 30, 2025 | $6.72M |
| Stockholders Equity | Q2 2026 · Oct 31, 2025 | $22.3M |
| Stockholders Equity | Q2 2026 · Jul 31, 2025 | $24.19M |
| Stockholders Equity | Q2 2026 · Apr 30, 2025 | $26.65M |
| Stockholders Equity | Q2 2026 · Oct 31, 2024 | $22.12M |
| Stockholders Equity | Q2 2026 · Jul 31, 2024 | $22.31M |
| Stockholders Equity | Q2 2026 · Apr 30, 2024 | $19.34M |
| Current Liabilities | Q2 2026 · Oct 31, 2025 | $15.36M |
| Current Liabilities | Q2 2026 · Apr 30, 2025 | $3.29M |
| Total Liabilities | Q2 2026 · Oct 31, 2025 | $17.02M |
| Total Liabilities | Q2 2026 · Apr 30, 2025 | $4.14M |
| Current Assets | Q2 2026 · Oct 31, 2025 | $18.93M |
| Current Assets | Q2 2026 · Apr 30, 2025 | $13.62M |
| Total Assets | Q2 2026 · Oct 31, 2025 | $39.32M |
| Total Assets | Q2 2026 · Apr 30, 2025 | $30.79M |
| Eps Diluted | Q2 2026 · Oct 31, 2025 | −$0.06 |
| Eps Diluted | Q2 2026 · Oct 31, 2025 | −$0.10 |
| Eps Diluted | Q2 2026 · Oct 31, 2024 | −$0.04 |
| Eps Diluted | Q2 2026 · Oct 31, 2024 | −$0.09 |
| Eps Basic | Q2 2026 · Oct 31, 2025 | −$0.06 |
| Eps Basic | Q2 2026 · Oct 31, 2025 | −$0.10 |
| Eps Basic | Q2 2026 · Oct 31, 2024 | −$0.04 |
| Eps Basic | Q2 2026 · Oct 31, 2024 | −$0.09 |
| Rd Expense | Q2 2026 · Oct 31, 2025 | $300K |
| Rd Expense | Q2 2026 · Oct 31, 2025 | $400K |
| Rd Expense restated | Q2 2026 · Oct 31, 2024 | $600K |
| Rd Expense restated | Q2 2026 · Oct 31, 2024 | $700K |
| Net Income | Q2 2026 · Oct 31, 2025 | −$10.83M |
| Net Income | Q2 2026 · Oct 31, 2025 | −$18.21M |
| Net Income | Q2 2026 · Oct 31, 2024 | −$3.91M |
| Net Income | Q2 2026 · Oct 31, 2024 | −$8.37M |
| Operating Income | Q2 2026 · Oct 31, 2025 | −$10.12M |
| Operating Income | Q2 2026 · Oct 31, 2025 | −$17.2M |
| Operating Income | Q2 2026 · Oct 31, 2024 | −$3.92M |
| Operating Income | Q2 2026 · Oct 31, 2024 | −$8.39M |
| Gross Profit | Q2 2026 · Oct 31, 2025 | −$1.38M |
| Gross Profit | Q2 2026 · Oct 31, 2025 | −$1.4M |
| Gross Profit | Q2 2026 · Oct 31, 2024 | $795K |
| Gross Profit | Q2 2026 · Oct 31, 2024 | $1.24M |
| Cost Of Revenue | Q2 2026 · Oct 31, 2025 | $1.8M |
| Cost Of Revenue | Q2 2026 · Oct 31, 2025 | $3.01M |
| Cost Of Revenue | Q2 2026 · Oct 31, 2024 | $1.62M |
| Cost Of Revenue | Q2 2026 · Oct 31, 2024 | $2.48M |